Jessica Merrill
Writes for:
Latest From Jessica Merrill
CVS CEO Merlo On COVID-19 Vaccination: "Think Of It Like Booking A Travel Ticket"
The pharmacy will be ready to begin COVID-19 vaccinations 48 hours after receiving the vaccine, Merlo said, outlining plans for a mass vaccination effort that will include online appointments.
Biogen And Sage On Plans To Build A Brain Franchise Together
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.
Pfizer Holds Number One Spot And Takeda Breaks The Top 10
Takeda's acquisition of Shire fueled the company into a top 10 pharma company in the latest Scrip 100 rankings, as other mega-mergers are set to shape the leaderboard in the future.
A Biopharma A-List Lineup Aims To Tackle Complex Manufacturing At Resilience
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Regeneron Leaders On Getting A Call From Trump And Building A Bioreactor Farm
Regeneron CEO Len Schleifer and President George Yancopoulos talked at the Stat Summit about launching their COVID-19 antibody cocktail and planning for the next pandemic.
Bill Gates On Vaccine Distribution Challenges, Overcoming Vaccine Hesitancy
The public health advocate and billionaire philanthropist raised issues about how a mass COVID-19 vaccination effort is being handled so far in the US, speaking at the Stat Summit.